These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 7893672
21. In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor. Tapparelli C, Metternich R, Ehrhardt C, Zurini M, Claeson G, Scully MF, Stone SR. J Biol Chem; 1993 Mar 05; 268(7):4734-41. PubMed ID: 8444849 [Abstract] [Full Text] [Related]
22. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models. Bertrand JA, Oleksyszyn J, Kam CM, Boduszek B, Presnell S, Plaskon RR, Suddath FL, Powers JC, Williams LD. Biochemistry; 1996 Mar 12; 35(10):3147-55. PubMed ID: 8605148 [Abstract] [Full Text] [Related]
23. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes. Stoll VS, Eger BT, Hynes RC, Martichonok V, Jones JB, Pai EF. Biochemistry; 1998 Jan 13; 37(2):451-62. PubMed ID: 9425066 [Abstract] [Full Text] [Related]
25. Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding mode. von Matt A, Ehrhardt C, Burkhard P, Metternich R, Walkinshaw M, Tapparelli C. Bioorg Med Chem; 2000 Sep 13; 8(9):2291-303. PubMed ID: 11026541 [Abstract] [Full Text] [Related]
26. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor. Chirgadze NY, Sall DJ, Klimkowski VJ, Clawson DK, Briggs SL, Hermann R, Smith GF, Gifford-Moore DS, Wery JP. Protein Sci; 1997 Jul 13; 6(7):1412-7. PubMed ID: 9232642 [Abstract] [Full Text] [Related]
27. Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A. Maryanoff BE, Qiu X, Padmanabhan KP, Tulinsky A, Almond HR, Andrade-Gordon P, Greco MN, Kauffman JA, Nicolaou KC, Liu A. Proc Natl Acad Sci U S A; 1993 Sep 01; 90(17):8048-52. PubMed ID: 8367461 [Abstract] [Full Text] [Related]
28. Exploring the chiral space within the active site of alpha-thrombin with a constrained mimic of D-Phe-Pro-Arg--design, synthesis, inhibitory activity, and X-ray structure of an enzyme-inhibitor complex. Hanessian S, Balaux E, Musil D, Olsson LL, Nilsson I. Bioorg Med Chem Lett; 2000 Feb 07; 10(3):243-7. PubMed ID: 10698445 [Abstract] [Full Text] [Related]
29. Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein. Zervosen A, Herman R, Kerff F, Herman A, Bouillez A, Prati F, Pratt RF, Frère JM, Joris B, Luxen A, Charlier P, Sauvage E. J Am Chem Soc; 2011 Jul 20; 133(28):10839-48. PubMed ID: 21574608 [Abstract] [Full Text] [Related]
32. Interactions of hirudin-based inhibitor with thrombin: critical role of the IleH59 side chain of the inhibitor. Tsuda Y, Szewczuk Z, Wang J, Yue SY, Purisima E, Konishi Y. Biochemistry; 1995 Jul 11; 34(27):8708-14. PubMed ID: 7612610 [Abstract] [Full Text] [Related]
33. Crystal structure of a peptidyl pyridinium methyl ketone inhibitor with thrombin. Rehse PH, Steinmetzer T, Li Y, Konishi Y, Cygler M. Biochemistry; 1995 Sep 12; 34(36):11537-44. PubMed ID: 7547884 [Abstract] [Full Text] [Related]
34. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety. Malikayil JA, Burkhart JP, Schreuder HA, Broersma RJ, Tardif C, Kutcher LW, Mehdi S, Schatzman GL, Neises B, Peet NP. Biochemistry; 1997 Feb 04; 36(5):1034-40. PubMed ID: 9033393 [Abstract] [Full Text] [Related]
35. Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues. Fraser ME, Strynadka NC, Bartlett PA, Hanson JE, James MN. Biochemistry; 1992 Jun 09; 31(22):5201-14. PubMed ID: 1606144 [Abstract] [Full Text] [Related]
36. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. Zdanov A, Wu S, DiMaio J, Konishi Y, Li Y, Wu X, Edwards BF, Martin PD, Cygler M. Proteins; 1993 Nov 09; 17(3):252-65. PubMed ID: 8272424 [Abstract] [Full Text] [Related]
37. New peptide boronic acid inhibitors of thrombin. Elgendy S, Deadman J, Claeson G. Adv Exp Med Biol; 1993 Nov 09; 340():173-8. PubMed ID: 8154333 [No Abstract] [Full Text] [Related]
38. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin. Féthière J, Tsuda Y, Coulombe R, Konishi Y, Cygler M. Protein Sci; 1996 Jun 09; 5(6):1174-83. PubMed ID: 8762149 [Abstract] [Full Text] [Related]
39. Kinetic properties of the binding of alpha-lytic protease to peptide boronic acids. Kettner CA, Bone R, Agard DA, Bachovchin WW. Biochemistry; 1988 Oct 04; 27(20):7682-8. PubMed ID: 3207699 [Abstract] [Full Text] [Related]
40. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays. Dreyer GB, Lambert DM, Meek TD, Carr TJ, Tomaszek TA, Fernandez AV, Bartus H, Cacciavillani E, Hassell AM, Minnich M. Biochemistry; 1992 Jul 28; 31(29):6646-59. PubMed ID: 1637805 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]